Madrigal Pharmaceuticals, Inc. (MDGL)
432.00
-13.85
(-3.11%)
USD |
NASDAQ |
Feb 27, 16:00
432.50
+0.50
(+0.12%)
After-Hours: 20:00
Madrigal Pharmaceuticals Research and Development Expense (TTM) : 387.02M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insmed, Inc. | 771.09M |
| Pfizer Inc. | 10.25B |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Eli Lilly & Co. | 13.34B |
| Johnson & Johnson | 14.72B |